Summary & Overview
HCPCS L8659: Interphalangeal Finger Joint Replacement, Metal/Ceramic
HCPCS Level II code L8659 denotes an interphalangeal finger joint replacement device made of two or more pieces combining metal and a ceramic-like material for surgical implantation. This device-level code is relevant for surgical reconstruction of finger joint function and is important nationally because it affects coverage determinations, coding accuracy for operative supply billing, and postoperative device tracking. Payers commonly involved in coverage and claims adjudication for implantable devices include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical purpose of the device, payer coverage considerations, and the operational context for billing and claims submission. The publication summarizes benchmark elements and typical policy drivers that influence payment and authorization for implantable finger joint prostheses, and it outlines the clinical setting and common billing modifiers used with device supply codes. Where specific data points or comparative metrics are not provided in the input, the text notes that those data are not available. The content is intended for national audiences including coding professionals, surgical teams, and revenue-cycle staff seeking clear, policy-focused context for L8659 rather than procedural guidance.
Billing Code Overview
HCPCS Level II code L8659 describes an interphalangeal finger joint replacement device composed of two or more pieces with metal (for example, stainless steel or cobalt chrome) and a ceramic-like material (for example, pyrocarbon) intended for surgical implantation, any size.
Service type: Surgical implantable joint prosthesis for the interphalangeal joints of the fingers.
Typical site of service: Hospital operating room or ambulatory surgical center for implantation during a surgical procedure.
Clinical & Coding Specifications
Clinical Context
A 62-year-old right-hand–dominant patient with progressive pain, stiffness, and deformity of the proximal interphalangeal (PIP) joint of the index finger presents after failure of conservative care (splinting, NSAIDs, corticosteroid injection, and hand therapy). Imaging shows advanced degenerative changes with joint space loss and osteophyte formation. The orthopedic hand surgeon recommends surgical reconstruction with an interphalangeal finger joint arthroplasty using a two-piece metal and pyrocarbon implant (L8659).
Preoperative workflow includes history and physical, informed consent discussing implant type and risks, preoperative clearance (cardiac risk assessment if indicated), and template radiographs for implant sizing. Intraoperative steps: regional block or general anesthesia, dorsal or lateral approach to the PIP joint, soft tissue releases and osteophyte removal, bone preparation, trialing, and implantation of the two-piece metal/ceramic-like prosthesis. Closure and postoperative splinting follow. Typical postoperative care includes wound checks, suture removal at 10–14 days, and progressive hand therapy focusing on range of motion and strengthening. Potential clinical indications include painful osteoarthritis, posttraumatic arthritis, and certain inflammatory arthritides when joint preservation or arthrodesis is not preferred.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier |